期刊文献+

Caveolin-1对宫颈癌细胞增殖和迁移能力的影响及其机制 被引量:4

Effect of Caveolin- 1 on proliferation and migration of cervical cancer cells and the mechanism
原文传递
导出
摘要 目的探讨Caveolin-1对宫颈癌细胞增殖和迁移能力的影响及其机制。方法体外培养宫颈癌细胞株Hela,将细胞株分为实验组、阴性对照组和正常对照组,实验组为运用质粒转染技术建立过表达的稳定细胞株Hela/Caveolin-1,空载体细胞株Hela/pc DNA3.1作为阴性对照组,正常对照组为未转染的常规培养细胞。采用RT-PCR方法检测3组细胞中Caveolin-1的表达水平,MTT方法检测宫颈癌细胞增殖能力,Transwell细胞侵袭实验测定转染Caveolin-1后宫颈癌细胞的侵袭和迁移能力。结果 RT-PCR方法结果说明,Hela/Caveolin-1实验组中Caveolin-1的表达(5.82±0.19)明显高于阴性对照组(1.19±0.01)和正常对照组(1.32±0.06),且实验组Hela细胞的增殖和迁移能力显著减弱。结论 Caveolin-1与宫颈癌细胞的增殖和迁移能力有关。 Objective To explore the effect of Caveolin-1 on proliferation and migration of cervical cancer cells and the mechanism. Methods Cervical cancer HeLa cells were cultured in vitro, then the cells were divided into experimental group, negative control group, and normal control group; experimental group included overexpression HeLa/Caveolin-1 cells established by plasmid transfection technique, negative control group included empty vector HeLa./pcDNA3.1 cells, normal control group included conventional culture ceils without trans- fection. RT-PCR was used to detect the expression levels of Caveolin-1 in the three groups, MTT assay was used to detect proliferation abil- ity of cervical cancer cells, Transwell assay was used to detect invasion and migration of cervical cancer cells transfeeted by Caveolin- 1. Re- stilts The expression level of Caveolin-1 in experimental group was (5. 82±0. 19), which was significantly higher than those in negative control group (1.19±0.01) and normal control group (1.32±0. 06), proliferation and migration of cervical cancer cells in experimental group weakened significantly. Conclusion Caveolin-1 is related to proliferation and migration of cervical cancer cells.
出处 《中国妇幼保健》 CAS 2016年第3期608-610,共3页 Maternal and Child Health Care of China
基金 承德市科学研究与发展计划项目(20122138) 承德青年科研基金资助项目(201310)
关键词 CAVEOLIN-1 HELA 增殖和迁移 RT-PCR Caveolin- 1 HeLa Proliferation and migration RT-PCR
  • 相关文献

参考文献9

二级参考文献70

  • 1梁菲,姜洁,李少儒,刘洋,李卫华,程世杰,成磊.小窝蛋白-1在卵巢癌组织中表达及其预后意义[J].肿瘤,2010,30(11):950-954. 被引量:1
  • 2许岸高,姜泊,钟旭辉,余志金,刘集鸿.广东地区近20年大肠癌临床特征的变化趋势[J].中华医学杂志,2006,86(4):272-275. 被引量:86
  • 3沈在雄,曹林升.Caveolin-1与泌尿系肿瘤研究进展[J].国际泌尿系统杂志,2006,26(6):806-809. 被引量:3
  • 4王华斌,姚珍薇,干晓琴,李刚,袁瑞,乐爱文.CO_2对人宫颈癌细胞株CASKI的增殖及CDK4和Cyclin D1表达的研究[J].重庆医科大学学报,2007,32(4):384-386. 被引量:6
  • 5Sung JJ,Lau JY,Goh KL,Leung WK: Increasing incidence of colorectal cancer in asia: Implications for screening[ J ]. Lancet Oncol 2005; 6:871-876.
  • 6Sotgia F,Williams TM,Cohen AW,Minetti C,Pestell RG,Lisanti MP: Caveolin-1-deficient mice have an increased mammary stem cell population with upregulation of wnt/beta-catenin signaling [J]. Cell Cycle 2005;4:1808-1816.
  • 7Masunaga R,Kohno H,Dhar DK,Ohno S,Shibakita M,Kinugasa S, Yoshimura H,Tachibana M, Kubota H, Nagasue N: Cyclooxygenase-2 expression correlates with tumor neovasetdarization and prognosis in human eoloreetal carcinoma patients [J] . Clin Cancer Res 2000;6: 4064-4068.
  • 8Shi L,Chen XM,Wang L,Zhang L,Chen Z: Expression of caveolin-1 in mucoepidermoid carcinoma of the salivary glands: Correlation with vascular endothelial growth factor,microvessel density,and clinical outcome[J]. Cancer 2007; 109:1523-1531.
  • 9Engelman JA, Wykoff CC, Yasuhara S, Song KS, Okamoto T, Lisanti MP: Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth[J] . J Biol Chem 1997;272:16374-16381.
  • 10Galbiati F,Volonte D,Engelman JA,Watanabe G, Burk R,Pestell RG,Lisanti MP: Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 map kinase cascade[J]. Embo J 1998; 17:6633-6648.

共引文献14

同被引文献28

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部